Comparative Pharmacology
Head-to-head clinical analysis: METHADOSE versus TYLENOL W CODEINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: METHADOSE versus TYLENOL W CODEINE.
METHADOSE vs TYLENOL W/ CODEINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Methadone is a mu-opioid receptor agonist; it also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake, contributing to its analgesic and detoxification effects. It has a long half-life and reduces opioid craving and withdrawal symptoms.
Codeine is a prodrug that is metabolized to morphine, which acts as a mu-opioid receptor agonist; acetaminophen inhibits cyclooxygenase (COX) and modulates descending serotonergic pathways.
Oral: 20-40 mg once daily, titrated to effect; for opioid dependence, typical maintenance 80-120 mg/day. IV: 2.5-10 mg every 8-12 hours.
1-2 tablets (300-600 mg acetaminophen / 30-60 mg codeine) every 4-6 hours as needed; maximum 12 tablets/day (codeine max 360 mg, acetaminophen max 3600 mg). Route: oral.
None Documented
None Documented
Terminal elimination half-life range: 8–59 hours (mean ~20–35 hours). In chronic use, half-life may increase due to accumulation. Context: The long half-life supports once-daily dosing for opioid dependence but requires careful titration to avoid accumulation.
Acetaminophen: 2-3 hours (prolonged in hepatic impairment). Codeine: 2.5-4 hours (slower in CYP2D6 poor metabolizers).
Primarily renal (approximately 80%) as inactive metabolites, with about 20% eliminated via feces. Less than 10% excreted unchanged.
Renal: ~90% as glucuronide conjugates (acetaminophen 50-70%, codeine 10-15%), 10-15% as free acetaminophen, <5% free codeine; biliary/fecal: <5%.
Category C
Category D/X
Opioid Agonist
Opioid Agonist